Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Methods in Enzymology
|
December 13, 2005
Assays for high-throughput screening of E2 AND E3 ubiquitin ligases
John H Kenten, Ilia V Davydov, Yassamin J Safiran, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2005
RGS4 and RGS5 are in vivo substrates of the N-end rule pathway
Min Jae Lee, Takafumi Tasaki, Kayoko Moroi, et al.
Methods in Enzymology
|
December 13, 2005
In vitro screening for substrates of the N-end rule-dependent ubiquitylation
Ilia V Davydov, John H Kenten, Yassamin J Safiran, et al.
The Journal of Biological Chemistry
|
September 1, 2006
Arginyltransferase, its specificity, putative substrates, bidirectional promoter, and splicing-derived isoforms
Rong-Gui Hu, Christopher S Brower, Haiqing Wang, et al.
Molecular and Cellular Biology
|
August 2, 2005
A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons
Takafumi Tasaki, Lubbertus C F Mulder, Akihiro Iwamatsu, et al.
Molecular and Cellular Biology
|
October 31, 2003
Female lethality and apoptosis of spermatocytes in mice lacking the UBR2 ubiquitin ligase of the N-end rule pathway
Yong Tae Kwon, Zanxian Xia, Jee Young An, et al.
Science (New York, N.Y.)
|
July 6, 2002
An essential role of N-terminal arginylation in cardiovascular development
Yong Tae Kwon, Anna S Kashina, Ilia V Davydov, et al.
Journal of Biomolecular Screening
|
February 14, 2008
Identification of inhibitors for MDM2 ubiquitin ligase activity from natural product extracts by a novel high-throughput electrochemiluminescent screen
Christy A Sasiela, David H Stewart, Jirouta Kitagaki, et al.
Cancer Cell
|
June 14, 2005
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells
Yili Yang, Robert L Ludwig, Jane P Jensen, et al.
Cancer Research
|
October 3, 2007
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics
Yili Yang, Jirouta Kitagaki, Ren-Ming Dai, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Methods in Enzymology
|
December 13, 2005
Assays for high-throughput screening of E2 AND E3 ubiquitin ligases
John H Kenten, Ilia V Davydov, Yassamin J Safiran, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2005
RGS4 and RGS5 are in vivo substrates of the N-end rule pathway
Min Jae Lee, Takafumi Tasaki, Kayoko Moroi, et al.
Methods in Enzymology
|
December 13, 2005
In vitro screening for substrates of the N-end rule-dependent ubiquitylation
Ilia V Davydov, John H Kenten, Yassamin J Safiran, et al.
The Journal of Biological Chemistry
|
September 1, 2006
Arginyltransferase, its specificity, putative substrates, bidirectional promoter, and splicing-derived isoforms
Rong-Gui Hu, Christopher S Brower, Haiqing Wang, et al.
Molecular and Cellular Biology
|
August 2, 2005
A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons
Takafumi Tasaki, Lubbertus C F Mulder, Akihiro Iwamatsu, et al.
Molecular and Cellular Biology
|
October 31, 2003
Female lethality and apoptosis of spermatocytes in mice lacking the UBR2 ubiquitin ligase of the N-end rule pathway
Yong Tae Kwon, Zanxian Xia, Jee Young An, et al.
Science (New York, N.Y.)
|
July 6, 2002
An essential role of N-terminal arginylation in cardiovascular development
Yong Tae Kwon, Anna S Kashina, Ilia V Davydov, et al.
Journal of Biomolecular Screening
|
February 14, 2008
Identification of inhibitors for MDM2 ubiquitin ligase activity from natural product extracts by a novel high-throughput electrochemiluminescent screen
Christy A Sasiela, David H Stewart, Jirouta Kitagaki, et al.
Cancer Cell
|
June 14, 2005
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells
Yili Yang, Robert L Ludwig, Jane P Jensen, et al.
Cancer Research
|
October 3, 2007
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics
Yili Yang, Jirouta Kitagaki, Ren-Ming Dai, et al.
Page
of 1